Requested when AstraZeneca might produce a subsequent era vaccine to deal with new variants, AstraZeneca analysis chief Mene Pangalos stated “as quickly as attainable”.
“We’re working very laborious and we’re already speaking about not simply the variants that now we have to make in laboratories, but additionally the medical research that we have to run,” he stated in a briefing with media.
“We’re very a lot aiming to attempt to have one thing prepared by the autumn, so this yr.”
The companions are getting near having knowledge on the efficacy of their COVID-19 vaccine on older adults, Professor Andrew Pollard, director of the Oxford Vaccine Group, stated.